medline.ch Dermatologie Psoriasis

	Systemic Treatment and Outcome in Erythrodermic Psoriasis: A Retrospective Multicenter Study. Int J Dermatol Kögel J, Schuh S, Welzel J, Sticherling M, Sollfrank L, Berking C, Pumnea T, Glatzel V, French L, Lauffer F, Vitus MV, Biedermann T, Bauer S, Spindler M, Berneburg M, Niebel D. PMID: 41999064 [PubMed - as supplied by publisher]
	Molecular Biomarkers for Predicting Treatment Response in Psoriatic Arthritis. Rheum Dis Clin North Am Ribeiro AL, Barton A, Schwenk JM, Bertheussen H, de Wit M, Goodyear C, Siebert S, Pennington SR, FitzGerald O. PMID: 41997622 [PubMed - indexed for MEDLINE]
	Predictors of clinical response to biologics in psoriasis: A systematic review and meta-analysis. J Eur Acad Dermatol Venereol Mao X, Meng S, Wu P, Cao L, Wang L. PMID: 41995334 [PubMed - as supplied by publisher]
	Efficacy of Risankizumab in Moderate to Severe Psoriasis Considering Body Mass Index: A Scoping Review. Cureus Sarmiento K, Siqueiros M, Hernández M, Morales G, Orozco V, Pumarejo LF, Gonzalez AD. PMID: 41994714 [PubMed]
	Retrospective Analysis of Inflammatory Parameters and Vitamins' Levels in Psoriasis Patients: A Case-Control Study. J Inflamm Res Murshidi R, Bani Hamad S, Al Refaei A, Shewaikani N, Al-Nusair DA, Abu Tawileh HB, Murshidi M, Alzeerelhouseini HIA. PMID: 41993888 [PubMed]
	Efficacy and Safety of Xeligekimab Compared to Other IL-17A Inhibitors for Chinese Patients with Moderate-to-severe Plaque Psoriasis: A Matching-adjusted Indirect Comparisons. Acta Derm Venereol Ding Y, Liu W. PMID: 41992713 [PubMed - indexed for MEDLINE]
	Cell-type-specific causal effects of CEBPD in CD8â€‰+â€‰S100Bâ€‰+â€‰Tcells and ZFP36 in monocytes modulate the protective and risk phenotypes in psoriasis. Mamm Genome Huang L, Shi J. PMID: 41991682 [PubMed - indexed for MEDLINE]
	Canadian Treat-to-Target Practice Survey of Real-World Interventions and Strategies in Psoriasis (CAN TARGET PSORIASIS). Dermatol Ther (Heidelb) Yeung J, Grewal P, Lansang P, Vender R, Wiseman M, Zeinab RA, Barakat M, Prajapati VH. PMID: 41989658 [PubMed - as supplied by publisher]
	Guselkumab is effective in the treatment of Inverse psoriasis: a case report and literature review. Front Med (Lausanne) Wu Z, Xie X, Tang W, Wu Y, Zhang G, Zhu Q. PMID: 41987768 [PubMed]
	Scenario-based evaluation of large language models for reference accuracy in dermatology: literature retrieval on latent tuberculosis in psoriasis patients on anti-IL-17/23 therapy. Cutan Ocul Toxicol Altunisik N, Altunisik Toplu S, Turkmen D. PMID: 41987670 [PubMed - as supplied by publisher]
	Health-related quality of life in patients with psoriasis in Asian countries: a systematic review and meta-analysis of EQ-5D utility scores. Sci Rep K H, V P, Murugadoss H, Ayyasamy L, Haridoss M. PMID: 41986412 [PubMed - as supplied by publisher]
	Global epidemiology of psoriatic arthritis. Best Pract Res Clin Rheumatol Kalyoncu U, Ayan G. PMID: 41986169 [PubMed - as supplied by publisher]
	Divergent Paths: A Comprehensive Review of Mechanisms and Clinical Implications in Atopic Dermatitis and Psoriasis. Allergy Czarnowicki T, Sugita K, Yiu Z, Díez-Ribas S, Garcia-Jimenez I, Guttman-Yassky E, Santamaria-Babí LF. PMID: 41986088 [PubMed - as supplied by publisher]
	Study protocol for testing pharmacological conditioning as a drug dose reduction strategy in patients with psoriasis in a randomised controlled trial. BMJ Open Savvidou P, Hölsken S, Krefting F, Benson S, Sondermann W. PMID: 41985954 [PubMed - indexed for MEDLINE]
	Development of structural damage in the spine in patients with psoriatic arthritis: findings from a longitudinal cohort study. Rheumatology (Oxford) Kharouf F, Mehta P, Carrizo Abarza V, Gao S, Pereira D, Chow N, Gladman DD, Chandran V, Poddubnyy D. PMID: 41984822 [PubMed - as supplied by publisher]
	Nanotechnology advances for psoriasis treatment and future prospects. Discov Nano Hu H, Ma Z, Zhang Z, Chen Y, Hu K, Zhang P, Liu J. PMID: 41984395 [PubMed]
	Psychopathology in acne, psoriasis, and eczema patients: Pre- and post-treatment. J Health Psychol Costeris C, Petridou M. PMID: 41983509 [PubMed - as supplied by publisher]
	Update on the Etiology and Pathogenesis of Erythrodermic Psoriasis. J Inflamm Res Wang Y, Wang Y, Jin H. PMID: 41982475 [PubMed]
	Limited Effectiveness of IL-17 Inhibitors for Anti-TNF-Induced Psoriasis in Hidradenitis Suppurativa: A Multicenter Retrospective Study. Int J Dermatol Bascón L, Lluch-Galcerá JJ, Mora-Fernández V, Verdaguer-Faja J, Haselgruber S, Molina-Leyva A, Sin-Soler M, Garbayo-Salmons P, Mercader-Salvans J, Araya VL, Fernández-Crehuet P, Parra-Navarro L, Martin-Ezquerra G, Martin-Poch A, Carrascosa JM, Sampayo-Cordero M, Romaní J, Guilabert Vidal A. PMID: 41981919 [PubMed - as supplied by publisher]
	Controlling Symptoms versus Minimizing Negative Treatment Impact: A Grounded Theory Study of Heterogeneity in Patient Preferences for Psoriasis Treatments. Patient Prefer Adherence Szabo SM, Hawkins NS, Germeni E. PMID: 41978741 [PubMed]

Artikel 1 - 20 / 27781

Seite 1 von 1390

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung